Abstract
Background
The squamous cell carcinoma (SCC) of the posterior pharyngeal wall (PPW) is associated with poor oncological outcomes based on current literature data. We reported the preliminary outcomes of a potential new treatment protocol based on neoadjuvant chemotherapy (NCT) and transoral robotic surgery (TORS).
Methods
A retrospective single-center case series was performed including a total of 20 patients diagnosed with a SCC of the PPW between October 2010 and September 2021. All patients successfully completed TORS with neck dissection after NCT. Adjuvant treatment was performed in the presence of adverse pathologic features. Loco-regional control (LRC), overall survival (OS), and disease-specific survival (DSS) were defined as the time from surgery to tumor recurrence or death, as appropriate. Survival estimates were calculated by Kaplan–Meier analysis. Surgical data and post-operative functional outcomes were also reported.
Results
Estimated 3-year LRC, OS, and DSS rates (95% Confidence interval) were 59.7% (39.7–89.6), 58.6% (38.7–88.8), and 69.4% (49.9–96.6). The median hospital stay was 21 days (IQR 17.0–23.5). Oral diet and decannulation were achieved after a median of 14 days (IQR 12.0–15.0). Feeding tube and tracheostomy dependence after 6 months was observed in 3 (15%) and 2 (10%) patients, respectively.
Conclusions
The use of NCT followed by TORS for PPW SCC treatment appears to have good oncological and functional outcomes for both early and locally advanced cancers. Further randomized trials and site-specific guidelines are needed.
Similar content being viewed by others
Availability of data and material
Data and material are available on request.
References
de Virgilio A, Russo E, Costantino A et al (2020) A systematic review of different treatment strategies for the squamous cell carcinoma of the posterior pharyngeal wall. Eur Arch Otorhinolaryngol 277(10):2663–2672. https://doi.org/10.1007/s00405-020-05990-0
Lallemant B, Moriniere S, Ceruse P et al (2017) Transoral robotic surgery for squamous cell carcinomas of the posterior pharyngeal wall. Eur Arch Otorhinolaryngol 274(12):4211–4216. https://doi.org/10.1007/s00405-017-4771-9
Başaran B, Ünsaler S (2022) Carcinoma of the posterior wall of the hypopharynx: surgical treatment with larynx preservation. Braz J Otorhinolaryngol 88(2):174–180. https://doi.org/10.1016/j.bjorl.2020.05.013
Barzan L, Barra S, Franchin G et al (1995) Squamous cell carcinoma of the posterior pharyngeal wall: characteristics compared with the lateral wall. J Laryngol Otol 109(2):120–125. https://doi.org/10.1017/s0022215100129445
Network NCCN (2022) NCCN Clinical Practice Guidelines in Oncology—Head and Neck Cancers Version 1.2023. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Accessed 12 May 2023
Nakatsuka T, Harii K, Ueda K et al (1997) Preservation of the larynx after resection of a carcinoma of the posterior wall of the hypopharynx: versatility of a free flap patch graft. Head Neck 19(2):137–142. https://doi.org/10.1002/(sici)1097-0347(199703)19:2%3c137::aid-hed9%3e3.0.co;2-5
Lydiatt WM, Kraus DH, Cordeiro PG, Hidalgo DA, Shah JP (1996) Posterior pharyngeal carcinoma resection with larynx preservation and radial forearm free flap reconstruction: a preliminary report. Head Neck 18(6):501–505. https://doi.org/10.1002/(SICI)1097-0347(199611/12)18:6%3c501::AID-HED3%3e3.0.CO;2-6
Julieron M, Kolb F, Schwaab G et al (2001) Surgical management of posterior pharyngeal wall carcinomas: functional and oncologic results. Head Neck 23(2):80–86. https://doi.org/10.1002/1097-0347(200102)23:2%3c80::aid-hed1002%3e3.0.co;2-3
Jol JKAD, Quak JJ, de Bree R, Leemans CR (2003) Larynx preservation surgery for advanced posterior pharyngeal wall carcinoma with free flap reconstruction: a critical appraisal. Oral Oncol 39(6):552–558. https://doi.org/10.1016/S1368-8375(03)00037-X
Canis M, Wolff HA, Ihler F, Matthias C, Steiner W (2015) Oncologic results of transoral laser microsurgery for squamous cell carcinoma of the posterior pharyngeal wall. Head Neck 37(2):156–161. https://doi.org/10.1002/hed.23571
Dabas S, Gupta K, Ranjan R, Sharma AK, Shukla H, Dinesh A (2017) Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): a prospective trial. Oral Oncol 69:80–83. https://doi.org/10.1016/j.oraloncology.2017.04.010
de Virgilio A, Costantino A, Mercante G, di Maio P, Iocca O, Spriano G (2020) Trans-oral robotic surgery in the management of parapharyngeal space tumors: a systematic review. Oral Oncol 103:104581. https://doi.org/10.1016/j.oraloncology.2020.104581
Sampieri C, Pirola F, Costantino A et al (2023) Single-port versus multiport da Vinci system for transoral robotic surgery of hypopharyngeal and laryngeal carcinoma. Otolaryngol Head Neck Surg. https://doi.org/10.1002/OHN.287
Park YM, Keum KC, Kim HR et al (2018) A clinical trial of combination neoadjuvant chemotherapy and transoral robotic surgery in patients with T3 and T4 laryngo-hypopharyngeal cancer. Ann Surg Oncol 25(4):864–871. https://doi.org/10.1245/s10434-017-6208-5
Pene F, Avedian V, Eschwege F et al (1978) A retrospective study of 131 cases of carcinoma of the posterior pharyngeal wall. Cancer 42(5):2490–2493. https://doi.org/10.1002/1097-0142(197811)42:5%3c2490::aid-cncr2820420553%3e3.0.co;2-5
de Felice F, Blanchard P, Levy A et al (2016) Treatment of squamous cell carcinoma of the posterior pharyngeal wall: radiotherapy versus surgery. Head Neck 38(Suppl 1):E1722–E1729. https://doi.org/10.1002/hed.24307
Fein DA, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR (1993) Pharyngeal wall carcinoma treated with radiotherapy: impact of treatment technique and fractionation. Int J Radiat Oncol Biol Phys 26(5):751–757. https://doi.org/10.1016/0360-3016(93)90488-h
Talton BM, Elkon D, Kim JA, Fitz-Hugh GS, Constable WC (1981) Cancer of the posterior hypopharyngeal wall. Int J Radiat Oncol Biol Phys 7(5):597–599. https://doi.org/10.1016/0360-3016(81)90372-2
Yoshida K, Inoue T, Inoue T, Tanaka E, Shiomi H, Teshima T (2004) Treatment results of radiotherapy with or without surgery for posterior pharyngeal wall cancer of oropharynx and hypopharynx: prognostic value of tumor extension. Radiat Med 22(1):30–36
Cooper RA, Slevin NJ, Carrington BM, Sykes AJ, Birzgalis A, Mott D (2000) Radiotherapy for carcinoma of the posterior pharyngeal wall. Int J Oncol 16(3):611–615. https://doi.org/10.3892/ijo.16.3.611
Wang CC (1971) Radiotherapeutic management of carcinoma of the posterior pharyngeal wall. Cancer 27(4):894–896. https://doi.org/10.1002/1097-0142(197104)27:4%3c894::aid-cncr2820270420%3e3.0.co;2-p
Marks JE, Smith PG, Sessions DG (1985) Pharyngeal wall cancer. A reappraisal after comparison of treatment methods. Arch Otolaryngol 111(2):79–85. https://doi.org/10.1001/archotol.1985.00800040043003
Jensen K, Lambertsen K, Grau C (2007) Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 85(1):74–82. https://doi.org/10.1016/j.radonc.2007.06.004
McNeill R (1981) Surgical management of carcinoma of the posterior pharyngeal wall. Head Neck Surg 3(5):389–394. https://doi.org/10.1002/hed.2890030508
Teichgraeber JF, McConnel FM (1986) Treatment of posterior pharyngeal wall carcinoma. Otolaryngol Head Neck Surg 94(3):287–290. https://doi.org/10.1177/019459988609400305
de Virgilio A, Costantino A, Mercante G et al (2021) Transoral robotic surgery and intensity-modulated radiotherapy in the treatment of the oropharyngeal carcinoma: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 278(5):1321–1335. https://doi.org/10.1007/s00405-020-06224-z
Costantino A, Sampieri C, Pirola F, de Virgilio A, Kim S (2022) Development of machine learning models for the prediction of positive surgical margins in transoral robotic surgery (TORS). Head Neck. https://doi.org/10.1002/hed.27283
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethics approval
The Yonsei University College of Medicine review board approved the retrospective study.
Consent to participate
Patients signed an informed consent for the anonymous collection of data for the purposes of scientific research at the time of hospital admission.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Costantino, A., Meliante, P.G., Sampieri, C. et al. Neoadjuvant chemotherapy and transoral robotic surgery for the posterior pharyngeal wall carcinoma. Eur Arch Otorhinolaryngol 280, 4649–4655 (2023). https://doi.org/10.1007/s00405-023-08070-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-08070-1